Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
Most patients with phenylketonuria were unwilling to start treatment with Palynziq (pegvaliase-pqpz) due to concerns about its safety and the need to self-inject the medication under the skin, according to ... Read more
Homology Medicines announced promising preliminary data from its trial testing the safety and efficacy of HMI-102, a candidate gene therapy for treating adults with phenylketonuria (PKU). The phase 1/2 trial, ... Read more